CORRECTION article
Front. Bioeng. Biotechnol.
Sec. Biomaterials
Volume 13 - 2025 | doi: 10.3389/fbioe.2025.1601751
Corrigendum: Therapeutic Effects of Zoledronic Acid-Loaded Hyaluronic Acid/Polyethylene Glycol/Nano-Hydroxyapatite Nanoparticles on Osteosarcoma
Provisionally accepted
- 1Hunan Cancer Hospital, Xiangya School of Medicine, Central South University, Changsha, Hunan Province, China
- 2Zhejiang University-University of Edinburgh Institute, Haining, Zhejiang Province, China
- 3Fourth Affiliated Hospital, School of Medicine, Zhejiang University, Yiwu, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
• please read through all the templates before choosing • pick the most relevant text template(s) from the following page and delete all others.• edit the text as necessary, ensuring that the original incorrect text is included for the record, please see the below. • please do not use any extra formatting when editing the templates, and only modify the red text unless absolutely necessary • submit to Frontiers following the instructions on this page.When the original text contained incorrect information, to preserve the scientific record, please include that text when editing the below templates. For example:There was a mistake in the Funding statement, an incorrect number was used. The correct number is "2015C03Bd051.". The publisher apologizes for this mistake.The original version of this article has been updated. Template continues on the next page PAGE \* Arabic \* MERGEFORMAT 3The corrected [Figure 2] appear below.Reminder: Figures, tables, and images will be published under a Creative Commons CC-BY licence and permission must be obtained for use of copyrighted material from other sources (including re-published/adapted/modified/partial figures and images from the internet). It is the responsibility of the authors to acquire the licenses, to follow any citation instructions requested by third-party rights holders, and cover any supplementary charges.End of template, if you would like to request a correction for a reason not seen here, please contact the journal's Editorial Office
Keywords: nanoparticle, Osteosarcoma, Zoledronic Acid, tumor therapy, targeted therapy
Received: 28 Mar 2025; Accepted: 24 Apr 2025.
Copyright: © 2025 Xu, Qi, Sun, Zhong and Wu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Hongwei Wu, Fourth Affiliated Hospital, School of Medicine, Zhejiang University, Yiwu, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.